Sphera Funds Management’s Wave Life Sciences WVE Stock Holding History

Sphera Funds Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.97M	Buy	548,272 +140,106	+34%	+$1.83M	0.63%	59
2025 Q4	$6.94M	Buy	408,166 +358,166	+716%	+$3.64M	1.34%	24
2025 Q3	$366K	Buy	+50,000	New	+$405K	0.08%	109
2021 Q1	–	Sell	-414,959	Closed	-$3.27M	–	203
2020 Q4	$3.27M	Sell	414,959 -516,241	-55%	-$4.33M	0.29%	78
2020 Q3	$7.91M	Buy	931,200 +638,200	+218%	+$7M	0.78%	37
2020 Q2	$3.05M	Buy	+293,000	New	+$2.76M	0.29%	64
2019 Q3	–	Sell	-307,967	Closed	-$8.04M	–	104
2019 Q2	$8.04M	Buy	+307,967	New	+$8.64M	1.1%	25

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GSK plc London $599M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Sphera Funds Management's WVE Position: Q1 2026 in Review

Sphera Funds Management increased its Wave Life Sciences (WVE) stake by 34% in Q1 2026, buying an estimated $1.83M and bringing the position to 548,272 shares worth $3.97M. The position accounts for 0.63% of the portfolio, ranked #59.

Sphera Funds Management first reported a position in WVE in Q2 2019 and has held it in 7 quarters since. The position peaked at $8.04M in Q2 2019. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

Sphera Funds Management held 548,272 shares of Wave Life Sciences worth $3.97M as of Q1 2026.
Sphera Funds Management bought 140,106 Wave Life Sciences shares in Q1 2026, an estimated $1.83M.
Wave Life Sciences made up 0.63% of Sphera Funds Management's portfolio in Q1 2026, its #59 holding.
Sphera Funds Management first reported a position in Wave Life Sciences in Q2 2019 and has held it in 7 quarters since.
Sphera Funds Management's Wave Life Sciences position peaked at $8.04M in Q2 2019.
230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.